Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard B Fox

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Current Protocols in Pharmacology|February 2, 2012
Model of attention deficit hyperactivity disorder: five-trial, repeated acquisition inhibitory avoidance in spontaneously hypertensive rat pupsGerard B Fox
Journal of Biomedical Research|April 5, 2013
PET imaging for receptor occupancy: meditations on calculation and simplificationYumin Zhang, Gerard B Fox
Expert Opinion on Investigational Drugs|October 6, 2004
Perspectives on cognitive domains, H3 receptor ligands and neurological diseaseArthur A Hancock, Gerard B Fox
Expert Opinion on Drug Discovery|March 19, 2013
Pharmacological and functional magnetic resonance imaging techniques in CNS drug discoveryGerard B Fox, Steve McGaraughty, Yanping Luo
Biochemical Pharmacology|February 8, 2011
Translational medicine special issueMark Day, Gerard B Fox, Gerard J Marek
Molecular Interventions|March 28, 2006
Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disordersTimothy A Esbenshade, Gerard B Fox, Marlon D Cowart
The International Journal of Neuropsychopharmacology|March 4, 2010
D3 receptor target engagement in humans with ABT-925 using [11C](+)-PHNO PETMark Day, Earle Bain, Gerard Marek, et al.
Journal of Psychiatric Research|January 13, 2009
Differential responses in CBF and CBV to cocaine as measured by fMRI: implications for pharmacological MRI signals derived oxygen metabolism assessmentFeng Luo, Karl F Schmidt, Gerard B Fox, et al.
Molecular Interventions|January 6, 2010
Translational neuroimaging of the CNS: novel pathways to drug developmentGerard B Fox, Chih-Liang Chin, Feng Luo, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|July 5, 2008
Cognitive endpoints as disease biomarkers: optimizing the congruency of preclinical models to the clinicMark Day, Fuat Balci, Hong I Wan, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Current Protocols in Pharmacology|February 2, 2012
Model of attention deficit hyperactivity disorder: five-trial, repeated acquisition inhibitory avoidance in spontaneously hypertensive rat pupsGerard B Fox
Journal of Biomedical Research|April 5, 2013
PET imaging for receptor occupancy: meditations on calculation and simplificationYumin Zhang, Gerard B Fox
Expert Opinion on Investigational Drugs|October 6, 2004
Perspectives on cognitive domains, H3 receptor ligands and neurological diseaseArthur A Hancock, Gerard B Fox
Expert Opinion on Drug Discovery|March 19, 2013
Pharmacological and functional magnetic resonance imaging techniques in CNS drug discoveryGerard B Fox, Steve McGaraughty, Yanping Luo
Biochemical Pharmacology|February 8, 2011
Translational medicine special issueMark Day, Gerard B Fox, Gerard J Marek
Molecular Interventions|March 28, 2006
Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disordersTimothy A Esbenshade, Gerard B Fox, Marlon D Cowart
The International Journal of Neuropsychopharmacology|March 4, 2010
D3 receptor target engagement in humans with ABT-925 using [11C](+)-PHNO PETMark Day, Earle Bain, Gerard Marek, et al.
Journal of Psychiatric Research|January 13, 2009
Differential responses in CBF and CBV to cocaine as measured by fMRI: implications for pharmacological MRI signals derived oxygen metabolism assessmentFeng Luo, Karl F Schmidt, Gerard B Fox, et al.
Molecular Interventions|January 6, 2010
Translational neuroimaging of the CNS: novel pathways to drug developmentGerard B Fox, Chih-Liang Chin, Feng Luo, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|July 5, 2008
Cognitive endpoints as disease biomarkers: optimizing the congruency of preclinical models to the clinicMark Day, Fuat Balci, Hong I Wan, et al.
Pageof 7